SAR153191 (REGN88)
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for SAR153191 (REGN88), covering 2017-06-26 to 2017-09-01. Get the full timeline:
Most recent: Clinical Trial Update: Effect of SAR153191 (REGN88) With Methotrexate in Patients With Active Rheumatoid Arthritis Who Failed TNF-α Blockers [Phase 2]